Pfizer Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | $35.96B | $63.14B | $1.12B |
| FY2020 | $37.13B | $63.24B | $1.79B |
| FY2021 | $36.20B | $77.20B | $1.94B |
| FY2022 | $32.88B | $95.66B | $416.0M |
| FY2023 | $61.54B | $89.01B | $2.85B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | $35.96B | $63.14B | $1.12B |
| FY2020 | $37.13B | $63.24B | $1.79B |
| FY2021 | $36.20B | $77.20B | $1.94B |
| FY2022 | $32.88B | $95.66B | $416.0M |
| FY2023 | $61.54B | $89.01B | $2.85B |